Wang Lei, Zhang Xinmeng, Chen You, Flynn Charles R, English Wayne J, Samuels Jason M, Williams Brandon, Spann Matthew, Albaugh Vance L, Shu Xiao-Ou, Yu Danxia
Division of Epidemiology, Department of Medicine Vanderbilt University Medical Center Nashville TN USA.
Department of Computer Science Vanderbilt University Nashville TN USA.
J Am Heart Assoc. 2025 Mar 18;14(6):e038191. doi: 10.1161/JAHA.124.038191. Epub 2025 Mar 7.
We applied the novel Predicting Risk of Cardiovascular Disease EVENTs equations to evaluate cardiovascular-kidney-metabolic (CKM) health and estimated cardiovascular disease (CVD) risk after bariatric surgery.
Among 7804 patients (aged 20-79 years) undergoing bariatric surgery at Vanderbilt University Medical Center during 1999 to 2022, CVD risk factors from before surgery to 2 years after surgery were extracted from electronic health records. The 10- and 30-year risks of total CVD, atherosclerotic CVD, coronary heart disease, stroke, and heart failure (HF) were estimated for patients without CVD history at each time point (n=124-2910), using the social deprivation index-enhanced Predicting Risk of Cardiovascular Disease EVENTs equations. Paired tests or McNemar tests were used to compare pre- with postsurgery CKM health and CVD risk. Two-sample tests were used to compare CVD risk reduction between patient subgroups.
CKM health was significantly improved after surgery with lower systolic blood pressure, non-high-density lipoprotein cholesterol, and diabetes prevalence, and higher high-density lipoprotein and estimated glomerular filtration rate. The 10-year risks of total CVD and its subtypes decreased by 21.7% to 56.3% at 1 year after surgery and by 14.6% to 46.5% at 2 years after surgery, with the largest reduction observed for HF. Younger age, White race, >30% weight loss, and diabetes history were associated with greater HF risk reductions. Similar results were found for the 30-year CVD risk estimates.
Bariatric surgery significantly improves CKM health and reduces estimated CVD risk, particularly HF, by 47% to 56% within 1 to 2 years after surgery. HF risk reduction may vary by patient's demographics, weight loss, and disease history, which warrants further research.
我们应用新型心血管疾病事件预测方程来评估心血管-肾脏-代谢(CKM)健康状况,并估计减肥手术后的心血管疾病(CVD)风险。
在1999年至2022年期间于范德比尔特大学医学中心接受减肥手术的7804例患者(年龄20 - 79岁)中,从电子健康记录中提取手术前至术后2年的CVD风险因素。使用社会剥夺指数增强的心血管疾病事件预测方程,对每个时间点无CVD病史的患者(n = 124 - 2910)估计其10年和30年的总CVD、动脉粥样硬化性CVD、冠心病、中风和心力衰竭(HF)风险。采用配对t检验或McNemar检验比较手术前后的CKM健康状况和CVD风险。使用两样本t检验比较患者亚组之间的CVD风险降低情况。
术后CKM健康状况显著改善,收缩压、非高密度脂蛋白胆固醇和糖尿病患病率降低,高密度脂蛋白和估计肾小球滤过率升高。术后1年时,总CVD及其亚型的10年风险降低了21.7%至56.3%,术后2年时降低了14.6%至46.5%,其中HF的风险降低最为显著。年龄较轻、白人种族、体重减轻>30%和有糖尿病病史与HF风险降低幅度更大相关。30年CVD风险估计也得到了类似结果。
减肥手术可显著改善CKM健康状况,并降低估计的CVD风险,尤其是HF风险,在术后1至2年内降低47%至56%。HF风险降低可能因患者的人口统计学特征、体重减轻情况和疾病史而异,这值得进一步研究。